Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial - Vilgrain, V; Pereira, H; Assenat, E; SARAH Trial Group (Lancet Oncol, 2017)